Large granular lymphocyte leukemia
- PMID: 20425381
- DOI: 10.1007/s11899-007-0038-7
Large granular lymphocyte leukemia
Abstract
Clonal diseases of large granular lymphocytes (LGLs) represent a spectrum of clinically rare lymphoproliferative malignancies arising from either mature T-cell (CD3(+)) or natural killer (NK)-cell (CD3(-)) lineages. The clinical behavior of these disorders ranges from indolent to very aggressive. Patients with symptomatic indolent T-cell or NK-cell LGL leukemia are usually treated with immunosuppressive therapies; in contrast, aggressive T-cell or NK-cell LGL leukemias require intensive chemotherapy regimens. Novel targeted therapies are currently being tested in clinical studies.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources